RSS feed

Publications by Karsten Bruins Slot

14 publications found

Original articles

Berge E, Cohen G, Roaldsen MB, Lundström E, Isaksson E, Rudberg AS, Slot KB, Forbes J, Smith J, Drever J, Wardlaw JM, Lindley RI, Sandercock PA, Whiteley WN, IST-3 Collaborative Group (2016)
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
Lancet Neurol, 15 (10), 1028-34
DOI 10.1016/S1474-4422(16)30139-9, PubMed 27450474

Tzogani K, Skibeli V, Westgaard I, Dalhus M, Thoresen H, Slot KB, Damkier P, Hofland K, Borregaard J, Ersbøll J, Salmonson T, Pieters R, Sylvester R, Mickisch G, Bergh J, Pignatti F (2015)
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human use
Oncologist, 20 (2), 196-201
DOI 10.1634/theoncologist.2014-0177, PubMed 25616431

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Lancet, 379 (9834), 2352-63
DOI 10.1016/S0140-6736(12)60768-5, PubMed 22632908

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
Trials, 12, 252
DOI 10.1186/1745-6215-12-252, PubMed 22129158

Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA, UK Collaborators of IST (2011)
Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial
PLoS One, 6 (3), e16988
DOI 10.1371/journal.pone.0016988, PubMed 21445242

Slot KB, Murray V, Boysen G, Berge E (2009)
Thrombolytic treatment for stroke in the Scandinavian countries
Acta Neurol Scand, 120 (4), 270-6
DOI 10.1111/j.1600-0404.2009.01162.x, PubMed 19456310

Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M, Oxfordshire Community Stroke Project, Lothian Stroke Register, International Stroke Trial (UK) (2009)
Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts
Stroke, 40 (5), 1585-9
DOI 10.1161/STROKEAHA.108.531533, PubMed 19265057

Slot KB, Berge E (2009)
Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement
J Stroke Cerebrovasc Dis, 18 (1), 17-22
DOI 10.1016/j.jstrokecerebrovasdis.2008.06.009, PubMed 19110139

Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P et al. (2008)
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
Trials, 9, 37
DOI 10.1186/1745-6215-9-37, PubMed 18559104

Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, Oxfordshire Community Stroke Project, the International Stroke Trial (UK), Lothian Stroke Register (2008)
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
BMJ, 336 (7640), 376-9
DOI 10.1136/bmj.39456.688333.BE, PubMed 18230644

Slot KB, Berge E, Wardlaw J (2008)
Haemorrhagic transformation of a recent silent cerebral infarct during thrombolytic stroke treatment
BMJ Case Rep, 2008, bcr0620080266
DOI 10.1136/bcr.06.2008.0266, PubMed 21716819

Review articles

Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J (2012)
Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies
Stroke, 43 (11), 2904-9
DOI 10.1161/STROKEAHA.112.665331, PubMed 22996959

Other articles

Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
EPITHET--where next?
Lancet Neurol, 7 (7), 570-1; author reply 571-3
DOI 10.1016/S1474-4422(08)70123-6, PubMed 18565447

Theses

Slot KB (2009)
Thrombolytic treatment for acute ischaemic stroke: patients' and physicians' views, and potential longterm benefits
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 828, 1 b. (flere pag.)
BIBSYS 093727844, ISBN 978-82-8072-958-3